Life Sciences Consulting M&A Report 2022

M&A within the life sciences sector continues to be very active for consulting and technology companies. Along with recent attention-grabbing acquisitions, such as AmeriesourceBergen’s purchase of PharamaLex for $1.3bn in September 2022, there have been plenty of other trade deals, as well as many companies attracting investment from private equity.

Download the latest report for insight into the market, M&A activity, buyer universe, and valuation drivers. 

The content of this report is a compilation from a team with extensive experience in the Knowledge Economy, created to help you make well-informed, critical decisions about the future of your business.